Upgrade to SI Premium - Free Trial

Cognex Reports Record First Quarter Results

May 6, 2021 4:06 PM

NATICK, Mass.--(BUSINESS WIRE)-- Cognex Corporation (NASDAQ: CGNX) today reported financial results for the first quarter of 2021. The company announced new records for first quarter revenue, net income, and net income per diluted share. Table 1 below shows selected financial data for Q1-21 compared with Q1-20 and Q4-20.

Table 1

(Dollars in thousands, except per share amounts)

Revenue

Net Income

Net Income
per Diluted
Share

Non-GAAP
Net Income
per Diluted
Share*

Quarterly Comparisons

Current quarter: Q1-21

$239,027

$69,848

$0.39

$0.36

Prior year’s quarter: Q1-20

$167,235

$20,477

$0.12

$0.11

Change: Q1-20 to Q1-21

43%

241%

225%

227%

Prior quarter: Q4-20

$223,615

$69,345

$0.39

$0.32

Change: Q4-20 to Q1-21

7%

1%

0%

13%

*Non-GAAP net income per diluted share excludes restructuring and other charges and tax adjustments. A reconciliation from GAAP to Non-GAAP is shown in Exhibit 2 of this news release.

“Cognex started 2021 on a strong note,” said Robert J. Willett, Chief Executive Officer of Cognex. “We reported the highest first quarter revenue, net income, and earnings per share in our company’s 40-year history. We were highly profitable—reporting an operating margin of 33% in Q1-21 compared to 13% a year ago—demonstrating the leverage we have in our high-growth, high gross margin business model.”

Mr. Willett continued, “We are pleased with our achievements in the first quarter. Our strong momentum continued in the e-commerce sector of logistics. Business activity has been recovering in other end markets that have struggled over the past year. Most importantly, we introduced several innovative products in the areas of 3D vision, edge intelligence, and handheld barcode reading that we believe will contribute to revenue growth in years to come.”

Details of the Quarter

Statement of Operations Highlights – First Quarter of 2021

Balance Sheet Highlights – April 4, 2021

Financial Outlook – Q2 2021

Non-GAAP Financial Measures

Analyst Conference Call and Simultaneous Webcast

About Cognex Corporation

Cognex Corporation designs, develops, manufactures, and markets a wide range of image-based products, all of which use artificial intelligence (AI) techniques that give them the human-like ability to make decisions on what they see. Cognex products include machine vision systems, machine vision sensors, and barcode readers that are used in factories and distribution centers around the world where they eliminate production and shipping errors.

Cognex is the world's leader in the machine vision industry, having shipped more than 3 million image-based products, representing over $8 billion in cumulative revenue, since the company's founding in 1981. Headquartered in Natick, Massachusetts, USA, Cognex has offices and distributors located throughout the Americas, Europe, and Asia. For details, visit Cognex online at www.cognex.com.

Certain statements made in this news release, which do not relate solely to historical matters, are forward-looking statements. These statements can be identified by use of the words “expects,” “anticipates,” “estimates,” “believes,” “projects,” “intends,” “plans,” “will,” “may,” “shall,” “could,” “should,” and similar words and other statements of a similar sense. These statements are based on our current estimates and expectations as to prospective events and circumstances, which may or may not be in our control and as to which there can be no firm assurances given. These forward-looking statements, which include statements regarding business and market trends, future financial performance, the expected impact of the COVID-19 pandemic on our assets, business and results of operations, customer order rates and timing of related revenue, future product mix, restructuring and other cost-savings initiatives, research and development activities, new product offerings, capital expenditures, investments, acquisitions, liquidity, dividends and stock repurchases, strategic plans, and estimated tax benefits and expenses and other tax matters, involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include: (1) the impact, duration, and severity of the COVID-19 pandemic; (2) potential disruptions to our business due to restructuring activities; (3) the loss of, or curtailment of purchases by, large customers in the consumer electronics and logistics industries; (4) the reliance on revenue from the automotive industry; (5) the reliance on key suppliers to manufacture and deliver critical components for our products and potential disruptions in the supply chain; (6) the failure to effectively manage product transitions or accurately forecast customer demand; (7) the inability to design and manufacture high-quality products; (8) the inability to attract and retain skilled employees and maintain our unique corporate culture; (9) the failure to effectively manage our growth; (10) the inability to achieve growth in revenue and profits from the logistics industry; (11) the technological obsolescence of current products and the inability to develop new products; (12) the failure to properly manage the distribution of products and services; (13) the impact of competitive pressures; (14) the challenges in integrating and achieving expected results from acquired businesses; (15) potential disruptions in our business systems; (16) information security breaches; (17) the inability to protect our proprietary technology and intellectual property; (18) potential impairment charges with respect to our investments or acquired intangible assets; (19) exposure to additional tax liabilities; (20) fluctuations in foreign currency exchange rates and the use of derivative instruments; (21) our involvement in time-consuming and costly litigation; (22) unfavorable global economic conditions; (23) economic, political, and other risks associated with international sales and operations; and the other risks detailed in Cognex reports filed with the SEC, including its Form 10-K for the fiscal year ended December 31, 2020 and Form 10-Q for the fiscal quarter ended April 4, 2021. You should not place undue reliance upon any such forward-looking statements, which speak only as of the date made. Cognex disclaims any obligation to update forward-looking statements after the date of such statements.

Exhibit 1

COGNEX CORPORATION

Statements of Operations

(Unaudited)

Dollars in thousands, except per share amounts

Three-months Ended

April 4,
2021

December 31,
2020

March 29,
2020

Revenue

$

239,027

$

223,615

$

167,235

Cost of revenue (1)

54,045

55,160

41,200

Gross margin

184,982

168,455

126,035

Percentage of revenue

77

%

75

%

75

%

Research, development, and engineering expenses (1)

34,105

34,399

35,946

Percentage of revenue

14

%

15

%

21

%

Selling, general, and administrative expenses (1)

72,424

74,096

69,138

Percentage of revenue

30

%

33

%

41

%

Restructuring charges

875

Operating income

78,453

59,085

20,951

Percentage of revenue

33

%

26

%

13

%

Foreign currency gain (loss)

(1,008

)

4,007

(3,003

)

Investment and other income

1,386

1,828

5,046

Income before income tax expense (benefit)

78,831

64,920

22,994

Income tax expense (benefit)

8,983

(4,425

)

2,517

Net income

$

69,848

$

69,345

$

20,477

Percentage of revenue

29

%

31

%

12

%

Net income per weighted-average common and common-equivalent share:

Basic

$

0.40

$

0.40

$

0.12

Diluted

$

0.39

$

0.39

$

0.12

Weighted-average common and common-equivalent shares outstanding:

Basic

176,288

175,220

172,408

Diluted

179,971

178,590

175,602

Cash dividends per common share

$

0.060

$

2.060

$

0.055

Cash and investments per common share

$

4.96

$

4.37

$

4.92

Book value per common share

$

7.68

$

7.18

$

7.73

(1) Amounts include stock-based compensation expense, as follows:

Cost of revenue

$

248

$

324

$

354

Research, development, and engineering

4,003

2,805

5,366

Selling, general, and administrative

7,758

7,456

9,070

Total stock-based compensation expense

$

12,009

$

10,585

$

14,790

Exhibit 2

COGNEX CORPORATION

Reconciliation of Selected Items from GAAP to Non-GAAP

(Unaudited)

Dollars in thousands, except per share amounts

Three-months Ended

April 4,
2021

December 31,
2020

March 29,
2020

Discrete tax adjustments reconciliation

Income before income tax expense (benefit) (GAAP)

$

78,831

$

64,920

$

22,994

Income tax expense (benefit) (GAAP)

$

8,983

$

(4,425

)

$

2,517

Effective tax rate (GAAP)

11

%

(7

)%

11

%

Discrete tax benefit related to stock-based compensation

5,207

2,342

1,680

Discrete tax benefit (expense) related to tax return filings and other

11,441

(242

)

Total discrete tax adjustments

$

5,207

$

13,783

$

1,438

Income tax expense (Non-GAAP)

$

14,190

$

9,358

$

3,955

Effective tax rate (Non-GAAP)

18

%

14

%

17

%

Restructuring and other charges and discrete tax adjustments reconciliation

Net income (GAAP)

$

69,848

$

69,345

$

20,477

Excess and obsolete inventory charges

705

522

1,065

Restructuring charges

875

Tax effect on restructuring and other charges

(127

)

(196

)

(181

)

Discrete tax adjustments

(5,207

)

(13,783

)

(1,438

)

Net income (Non-GAAP)

$

65,219

$

56,763

$

19,923

Percentage of revenue (Non-GAAP)

27

%

25

%

12

%

Net income per diluted weighted-average common and common-equivalent share (GAAP)

$

0.39

$

0.39

$

0.12

Per share impact of non-GAAP adjustments identified above

(0.03

)

(0.07

)

(0.01

)

Net income per diluted weighted-average common and common-equivalent share (Non-GAAP)

$

0.36

$

0.32

$

0.11

Diluted weighted-average common and common-equivalent shares outstanding

179,971

178,590

175,602

Exhibit 3

COGNEX CORPORATION

Balance Sheets

(Unaudited)

Dollars in thousands

April 4, 2021

December 31, 2020

Assets

Cash and investments

$

876,284

$

767,438

Accounts receivable

128,822

125,696

Inventories

61,392

60,830

Property, plant, and equipment

77,081

79,173

Operating lease assets

20,784

22,582

Goodwill and intangible assets

257,664

259,633

Deferred tax assets

429,801

434,704

Other assets

57,128

50,646

Total assets

$

1,908,956

$

1,800,702

Liabilities and Shareholders' Equity

Accounts payable and accrued expenses

$

81,392

$

93,534

Deferred revenue and customer deposits

51,660

21,274

Operating lease liabilities

24,028

26,230

Income taxes

74,538

72,551

Deferred tax liabilities

310,884

314,952

Other liabilities

9,453

9,959

Shareholders' equity

1,357,001

1,262,202

Total liabilities and shareholders' equity

$

1,908,956

$

1,800,702

Susan Conway

Investor Relations

+1 508-650-3353

[email protected]

Source: Cognex Corporation

Categories

Business Wire Press Releases

Next Articles